Australia’s only facility exploring cell therapy manufacturing techniques is a step closer to commercialising potential life-saving medical technology following a deal with global leader in blood component and cellular technologies.
The Cell Therapy Manufacturing Cooperative Research Centre (CTMCRC) based at Mawson Lakes has recently concluded its first commercial transfer of intellectual property to Terumo BCT Australia Ltd, which holds more than 400 patents, and has about another 300 patents pending.
Health Industries Minister Jack Snelling said CTMCRC’s success is another step towards creating a cell manufacturing hub for the Asia-Pacific, here in Adelaide.
“The CTMCRC develops novel cell therapies with the aim of treating previously incurable or intractable conditions such as type 1 diabetes, diabetic wounds, and immune-mediated diseases,” Mr Snelling said.
“Given the very high costs, the CTMCRC aims to make such treatments more affordable and accessible…
Click here for media release